JELÍNKOVÁ, Šárka, Aneta KOHUTOVÁ, Petr FOJTÍK, Miriama KRUTÁ, Aleksandra VILOTIĆ, Martin PEŠL, Jan VRBSKÝ, Renata GAILLYOVÁ, Iveta VALÁŠKOVÁ, Ivan FRÁK, Giancarlo FORTE, Petr DVOŘÁK, Albano MELI, Vladimír ROTREKL, Lenka MARKOVÁ, Tereza JURÁKOVÁ and Alain LACAMPAGNE. Dystrophin Deficiency Leads to Genomic Instability in Human Pluripotent Stem Cells via NO Synthase-Induced Oxidative Stress. Cells. Basel: MDPI, 2019, vol. 8, No 1, p. 1-22. ISSN 2073-4409. Available from: https://dx.doi.org/10.3390/cells8010053.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Dystrophin Deficiency Leads to Genomic Instability in Human Pluripotent Stem Cells via NO Synthase-Induced Oxidative Stress
Authors JELÍNKOVÁ, Šárka (203 Czech Republic, belonging to the institution), Aneta KOHUTOVÁ (703 Slovakia, belonging to the institution), Petr FOJTÍK (203 Czech Republic, belonging to the institution), Miriama KRUTÁ (703 Slovakia, belonging to the institution), Aleksandra VILOTIĆ (688 Serbia, belonging to the institution), Martin PEŠL (203 Czech Republic, belonging to the institution), Jan VRBSKÝ (203 Czech Republic), Renata GAILLYOVÁ (203 Czech Republic, belonging to the institution), Iveta VALÁŠKOVÁ (203 Czech Republic, belonging to the institution), Ivan FRÁK (703 Slovakia, belonging to the institution), Giancarlo FORTE (380 Italy), Petr DVOŘÁK (203 Czech Republic, belonging to the institution), Albano MELI (250 France, belonging to the institution), Vladimír ROTREKL (203 Czech Republic, guarantor, belonging to the institution), Lenka MARKOVÁ (203 Czech Republic, belonging to the institution), Tereza JURÁKOVÁ (203 Czech Republic, belonging to the institution) and Alain LACAMPAGNE (250 France).
Edition Cells, Basel, MDPI, 2019, 2073-4409.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10601 Cell biology
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.366
RIV identification code RIV/00216224:14110/19:00107273
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.3390/cells8010053
UT WoS 000459742400053
Keywords in English DMD; dystrophin; pluripotent stem cells; genome stability; ROS; NO synthases
Tags 14110115, 14110513, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 29/4/2020 07:43.
Abstract
Recent data on Duchenne muscular dystrophy (DMD) show myocyte progenitor’s involvement in the disease pathology often leading to the DMD patient’s death. The molecular mechanism underlying stem cell impairment in DMD has not been described. We created dystrophin-deficient human pluripotent stem cell (hPSC) lines by reprogramming cells from two DMD patients, and also by introducing dystrophin mutation into human embryonic stem cells via CRISPR/Cas9. While dystrophin is expressed in healthy hPSC, its deficiency in DMD hPSC lines induces the release of reactive oxygen species (ROS) through dysregulated activity of all three isoforms of nitric oxide synthase (further abrev. as, NOS). NOS-induced ROS release leads to DNA damage and genomic instability in DMD hPSC. We were able to reduce both the ROS release as well as DNA damage to the level of wild-type hPSC by inhibiting NOS activity.
Links
GBP302/12/G157, research and development projectName: Dynamika a organizace chromosomů během buněčného cyklu a při diferenciaci v normě a patologii
Investor: Czech Science Foundation
MUNI/A/1087/2018, interní kód MUName: Molekulární a buněčná biologie pro biomedicínské vědy
Investor: Masaryk University, Category A
7AMB13FR011, research and development projectName: Přeprogramování somatických buněk darovaných pacienty s dědičnou Duchennovou svalovou dystrofií do kardiomyocytů - nahlédnutí do molekulární podstaty patologických dějů u dilatační kardiomyopatie nemocných DMD (Acronym: DUCHENSTEM)
Investor: Ministry of Education, Youth and Sports of the CR
PrintDisplayed: 20/7/2024 08:24